A World Without Poverty logo


A Rwandan medical team joined a Canadian and American research team to conduct a two year randomized clinical trial to study the use of selenium supplementation with HIV+ persons. The clinical trial involved 300 HIV+ patients at two hospital sites in Kigali, Rwanda. The outcome showed that those in the selenium arm of the study had a significant decrease in rate of decline of CD4 count, a marker indicating the declining state of health and the progression towards disease. This study suggests that using supplemental selenium, a low-cost nutritional supplement, could not only benefit the health of HIV+ patients, but could lower the cost of AIDS treatment in resource-limited settings by delaying the onset for the need of drug intervention. This is the first study of its kind to be conducted in Africa.


Click the link above to watch the video

Effect of Selenium Supplementation on CD4R T-Cell Recovery, Viral Suppression and Morbidity of HIV-Infected Patients in Rwanda: A Randomized Controlled Trial

Click above to download the full study

ArrowIcon BloggerIcon AimIcon DeliciousIcon PaperIcon EtsyIcon FacebookIcon FilmStripIcon FlickrIcon CameraIcon LaunchIcon GooglePlus2Icon GooglePlusIcon HeartIcon InformationIcon InstagramIcon LastfmIcon FrontCameraIcon LinkedInIcon EmailIcon MoneyIcon ItunesIcon MyspaceIcon OpenTableIcon PayPalIcon PencilIcon PersonIcon PhotoIcon PicasaIcon PinterestIcon PodcastIcon RssIcon ShoppingCartIcon SoundCloudIcon StarIcon TableProjectIcon TheCityIcon TumblrIcon Twitter2Icon TwitterIcon TypepadIcon VideoIcon VimeoIcon WordPressIcon YelpIcon YoutubeIcon